drugset / Trial / NCT06461299
Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
NaSingle-groupOpen-labelTreatment
Summary
A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Timeline
- Start
- 2023-07-17
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarecycline | Small molecule | 60 mg | Oral |
| Subject | Sarecycline | Small molecule | 100 mg | Oral |
| Subject | Sarecycline | Small molecule | 150 mg | Oral |